iJOBS Site Visit: Celgene

Event Description

There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocytic leukemia (CLL), non-Hodgkin’s lymphoma (NHL), triple-negative breast cancer and pancreatic cancer. Come hear from PhD level employees who work at Celgene and tour the CAR T-cell facility.

To view the contact list, click here.